Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Intervalo de año de publicación
1.
Rev. Bras. Saúde Mater. Infant. (Online) ; 20(2): 599-602, Apr.-June 2020.
Artículo en Inglés | Sec. Est. Saúde SP, LILACS | ID: biblio-1136436

RESUMEN

Abstract This research aims to reflect upon the inherent impacts of social isolation caused by the new coronavirus (COVID-19) pandemic on the health of pregnant women. It brings up a survey on both physical and psychological aspects of this period on a woman's life, such as physiological and emotional changes. It also raises questions about how these aspects can be directly or indirectly affected by periods of isolation, considering recent research and guidance from health reference organizations.


Resumo Esse texto tem como objetivo refletir sobre os impactos inerentes do isolamento social proveniente da pandemia do novo corona vírus (COVID-19) na saúde das gestantes. Traz um levantamento tanto sobre os aspectos físicos como psíquicos específicos desse período da vida da mulher, como as alterações fisiológicas e emocionais. Bem como, levanta questões de como esses aspectos podem ser afetados direto ou indiretamente em um momento de isolamento, apresentando reflexões sobre pesquisas atuais e orientações de órgãos de referência na saúde.


Asunto(s)
Humanos , Femenino , Embarazo , Aislamiento Social/psicología , Cuarentena/psicología , Mujeres Embarazadas/psicología , COVID-19 , Bienestar Materno
2.
Front Aging Neurosci ; 10: 334, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30450044

RESUMEN

Despite advances in the treatment of Alzheimer's disease (AD), there is currently no prospect of a cure, and evidence shows that multifactorial interventions can benefit patients. A promising therapeutic alternative is the use of transcranial direct current stimulation (tDCS) simultaneously with cognitive intervention. The combination of these non-pharmacological techniques is apparently a safe and accessible approach. This study protocol aims to compare the efficacy of tDCS and cognitive intervention in a double-blind, randomized and factorial clinical trial. One hundred participants diagnosed with mild-stage AD will be randomized to receive both tDCS and cognitive intervention, tDCS, cognitive intervention, or placebo. The treatment will last 8 weeks, with a 12-month follow-up. The primary outcome will be the improvement of global cognitive functions, evaluated by the AD Assessment Scale, cognitive subscale (ADAS-Cog). The secondary outcomes will include measures of functional, affective, and behavioral components, as well as a neurophysiological marker (Brain-derived neurotrophic factor, BDNF). This study will enable us to assess, both in the short and long term, whether tDCS is more effective than the placebo and to examine the effects of combined therapy (tDCS and cognitive intervention) and isolated treatments (tDCS vs. cognitive intervention) on patients with AD. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02772185-May 5, 2016.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...